Your browser doesn't support javascript.
loading
Synthesis, structural characterizations, in vitro biological evaluation and computational investigations of pyrazole derivatives as potential antidiabetic and antioxidant agents.
Mortada, Salma; Karrouchi, Khalid; Hamza, El Hadki; Oulmidi, Afaf; Bhat, Mashooq Ahamd; Mamad, Hassane; Aalilou, Youssra; Radi, Smaail; Ansar, M'hammed; Masrar, Azlarab; Faouzi, My El Abbes.
  • Mortada S; Laboratory of Pharmacology and Toxicology, Biopharmaceutical and Toxicological Analysis Research Team, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
  • Karrouchi K; Laboratory of Analytical Chemistry and Bromatology, Team of Formulation and Quality Control of Health Products, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco. khalid.karrouchi@um5s.net.ma.
  • Hamza EH; CERNE2D: Laboratory of Spectroscopy, Molecular Modelling, Materials, Nanomaterials, Water and Enviroment (LS3MN2E), Faculty of Sciences, Mohammed V University, Rabat, Morocco.
  • Oulmidi A; Institute of Condensed Matter and Nanosciences, Molecular Chemistry, Materials and Catalysis (IMCN/MOST), Université Catholique de Louvain, 1348, Louvain-la-Neuve, Belgium.
  • Bhat MA; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, 11451, Riyadh, Saudi Arabia.
  • Mamad H; Central Laboratory of Hematology, Ibn Sina Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
  • Aalilou Y; Laboratory of Pharmacology and Toxicology, Biopharmaceutical and Toxicological Analysis Research Team, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
  • Radi S; Laboratoire de Chimie Appliquée et Environnement (LCAE), Faculté des Sciences, Université Mohammed I, 60000, Oujda, Morocco.
  • Ansar M; Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
  • Masrar A; Central Laboratory of Hematology, Ibn Sina Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
  • Faouzi MEA; Laboratory of Pharmacology and Toxicology, Biopharmaceutical and Toxicological Analysis Research Team, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
Sci Rep ; 14(1): 1312, 2024 01 15.
Article en En | MEDLINE | ID: mdl-38225280
ABSTRACT
In this study, a two pyrazole derivatives; 2-(5-methyl-1H-pyrazole-3-carbonyl)-N-phenylhydrazine-1-carboxamide (Pyz-1) and 4-amino-5-(5-methyl-1H-pyrazol-3-yl)-4H-1,2,4-triazole-3-thiol (Pyz-2) were synthesized and characterized by 13C-NMR, 1H-NMR, FT-IR, and mass spectrometry. A complete molecular structures optimization, electronic and thermodynamic properties of Pyz-1 and Pyz-2 in gas phase and aqueous solution were predicted by using hybrid B3LYP method with the 6-311++G** basis sets. Pyz-1 and Pyz-2 were evaluated in vitro for their anti-diabetic, antioxidant and xanthine oxidase inhibition activities. For anti-diabetic activity, Pyz-1 and Pyz-2 showed a potent α-glucosidase and α-amylase inhibition with IC50 values of 75.62 ± 0.56, 95.85 ± 0.92 and 119.3 ± 0.75, 120.2 ± 0.68 µM, respectively, compared to Acarbose (IC50(α-glucosidase) = 72.58 ± 0.68 µM, IC50(α-amylase) = 115.6 ± 0.574 µM). In xanthine oxidase assay, Pyz-1 and Pyz-2 exhibited remarkable inhibitory ability with IC50 values 24.32 ± 0.78 and 10.75 ± 0.54 µM, respectively. The result of antioxidant activities showed that the title compounds have considerable antioxidant and radical scavenger abilities. In addition, molecular docking simulation was used to determine the binding modes and energies between the title compounds and α-glucosidase and α-amylase enzymes.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus / Hipoglucemiantes Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus / Hipoglucemiantes Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article